You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
The drug bank data needs to be examined and solutions developed for the extraction of meaningful terms and data regarding indications to help with the AMP/ASCO Tiering evaluation.
Values: Cancer type (ex. Non-Small Cell Lung Cancer or Microsatellite Instability-High Cancer)
Biomarker, not all indications will have this (ex. Non-Small Cell Lung Cancer (NSCLC); in combination with [pemetrexed] and platinum-based chemotherapy as a first-line treatment for patients with metastatic nonsquamous NSCLC with no EGFR or ALK mutations)
Combination drug (ex. "in combination with carboplatin and paclitaxel as a first-line treatment for patients with metastatic squamous NSCLC")
The text was updated successfully, but these errors were encountered:
The drug bank data needs to be examined and solutions developed for the extraction of meaningful terms and data regarding indications to help with the AMP/ASCO Tiering evaluation.
Values:
Cancer type (ex. Non-Small Cell Lung Cancer or Microsatellite Instability-High Cancer)
Biomarker, not all indications will have this (ex. Non-Small Cell Lung Cancer (NSCLC); in combination with [pemetrexed] and platinum-based chemotherapy as a first-line treatment for patients with metastatic nonsquamous NSCLC with no EGFR or ALK mutations)
Combination drug (ex. "in combination with carboplatin and paclitaxel as a first-line treatment for patients with metastatic squamous NSCLC")
The text was updated successfully, but these errors were encountered: